Q4 2014 13F Holders as of 12/31/2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
77.3M
-
Number of holders
-
16
-
Total 13F shares, excl. options
-
4.28M
-
Shares change
-
+3.82M
-
Total reported value, excl. options
-
$83.1M
-
Value change
-
+$74.1M
-
Number of buys
-
13
-
Price
-
$19.75
Significant Holders of Xenon Pharmaceuticals Inc. - Common Stock (XENE) as of Q4 2014
16 filings reported holding XENE - Xenon Pharmaceuticals Inc. - Common Stock as of Q4 2014.
Xenon Pharmaceuticals Inc. - Common Stock (XENE) has 16 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.28M shares
of 77.3M outstanding shares and own 5.53% of the company stock.
Largest 10 shareholders include FMR LLC (1.26M shares), Capital World Investors (659K shares), BVF INC/IL (618K shares), Visium Asset Management, LP (450K shares), Invesco Private Capital, Inc. (445K shares), EcoR1 Capital, LLC (328K shares), PERCEPTIVE ADVISORS LLC (225K shares), Novo A/S (128K shares), ROYAL BANK OF CANADA (101K shares), and CAISSE DE DEPOT ET PLACEMENT DU QUEBEC (22.5K shares).
This table shows the top 16 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.